| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Aug 2026 | 6 Aug 2026 |
| Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Standalone Unaudited Financial Results of the Company for the quarter ended 30th June 2026. 1. To fix day date time and venue of 40th Annual General Meeting and approve notice of 40th Annual General Meeting and board report. 2. To discuss and note Secretarial Audit Report. 3. To appoint scrutinizer for 40th Annual General Meeting 4. To propose the increase in Authorized Share Capital of the Company and consequential amendment in Memorandum of Association (MOA) and adoption of new set of Articles of Association (AOA) 5. To propose the offer issue and allotment of Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on Private Placement basis in one or more tranches along with the other agenda items detailed in the attached notice | ||
| Board Meeting | 27 May 2026 | 20 May 2026 |
| Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve Audited Financial Results for Quarter and Financial Year Ended On 31/03/2026 outcome of the meeting of the Board of director held on held on 27th May 2026 (As Per BSE Announcement Dated on 27.05.2026) | ||
| Board Meeting | 25 Mar 2026 | 25 Mar 2026 |
| Appointment of Internal Auditor for the Financial Year 2025-26 & 2026-27. | ||
| Board Meeting | 13 Feb 2026 | 4 Feb 2026 |
| Quarterly Results Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Standalone Unaudited Financial Results of the Company for the quarter ended December 31, 2025 and any other matter with the permission of the Chairman of the meeting Approval Of Unaudited Standalone Financial Result of the Company for the Quarter Ended On 31St December 2025 Unaudited standalone Financial Result for the quarter ended December 31, 2025 (As Per BSE Announcement Dated on:13.02.2026) | ||
| Board Meeting | 5 Dec 2025 | 5 Dec 2025 |
| Pursuant to Regulation 30 of the SEBI (LODR) Regulation 2015, the Board of Directors in the meeting held on 5th December 2025 approved the appointment of Mr. Suresh Lad as a Chief Financial Officer of the company w.e.f. 05th December 2025 | ||
| Board Meeting | 14 Nov 2025 | 4 Nov 2025 |
| Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Un-Audited Financial Results along with the Limited Review Report for the Quarter Ended 30th September 2025. This is to inform you that the Board of Directors of the Company at their meeting held today i.e. 14th November, 2025 have approved and adopted the Un-audited Financial Results of the Company for the quarter and half year ended 30th September, 2025, as reviewed and recommended by Audit Committee. Pursuant to the provisions of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following: 1. Un-audited Financial Results for the quarter and half year ended 30th September, 2025. 2. Limited Review Report, as issued by the Statutory Auditors of the Company. Please find attached the Quarterly Results along with the Limited Review Report for the quarter ended September, 2025 (As Per BSE Announcement Dated on:14.11.2025) Intimation of Newspaper Publication (As Per BSE Announcement Dated on 15.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
